Ciprofloxacin In Dextrose Injection, Solution
NDC Package 84549-300-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ciprofloxacin In Dextrose (ciprofloxacin) injection is a medication used to treat a variety of bacterial infections. This formulation utilizes a injection, solution delivery system. Marketed by Propharma Distribution, this product is identified by NDC 84549-300 and is authorized under FDA application ANDA078252.

Identification & Billing

NDC Package Code
84549-300-24
Package Description
200 mL in 1 BAG
Product Code
84549-300
11-Digit Billing Format
84549030024
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ciprofloxacin In Dextrose
Non-Proprietary Name
Ciprofloxacin
Substance Name
Ciprofloxacin
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
CIPROFLOXACIN 400 mg/200mL
Pharmacologic Class
Usage Information
This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Propharma Distribution
Product Type
Human Prescription Drug
FDA Application #
ANDA078252
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84549-300-24 identifies a specific commercial package of 200 ml in 1 bag of Ciprofloxacin In Dextrose, a human prescription drug labeled by Propharma Distribution. This injection, solution is formulated for intravenous use and contains ciprofloxacin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Propharma Distribution on December 01, 2022. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Propharma Distribution product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84549030024. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84549-300-24
11-Digit CMS (5-4-2)
84549-0300-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.